MHRA

How to apply for a regulatory advice meeting on medical devices and in vitro diagnostic devices.

A story of hope, medical innovation, and the impact of effective regulation on access to treatment.

As with all licensed medicines, we will continue to monitor its safety closely as it becomes more widely used

Patient factsheet to provide information on vaccines and vaccine safety.

An initiative to help drive advancements in healthcare, to ensure patients benefit from innovation and new treatments sooner.

List of Field Safety Notices from 24 to 28 November 2025.

An Expert Working Group has completed a review into how the potential risks associated with antidepressant medicines are communicated to patients

This is a work sharing model for the co-ordinated assessment of a generic application that has been filed with multiple Access Consortium agencies.

The MHRA has five top tips to help you stay well through the festive season and beyond

Summary of the latest safety advice for medicines and medical device users

Special Concept Development UK Limited has informed the MHRA that the Patient Information Leaflet (PIL) for the batches listed in this notification do not contain the correct safety information.

Additional funding will allow the MHRA and NICE to continue developing clear, proportionate guidance for digital mental health technologies, supporting safer, more effective tools for people across the UK.